We are looking for young people 2–17 years old to join a clinical research to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or moderate to severe IBD (including associated symptoms such as bloody diarrhea, loss of appetite, abdominal pain, chronic fatigue and/or eye pain), consider one of our GI clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people 2–17 years old may be eligible to take part.
Your child may be eligible to take part in the GI clinical trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child is eligible.
